Clinical Trial Update: Atorvastatin in Preventing Nasopharyngeal Carcinoma Patients Receiving Radiotherapy From Carotid Stenosis [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating atorvastatin to prevent carotid stenosis in nasopharyngeal carcinoma patients receiving radiotherapy has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carotid Artery Stenosis
• Nasopharyngeal Carcinoma

Drugs mentioned

• atorvastatin (atorvastatin)

Snippet

Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Conditions: Nasopharyngeal Carcinoma, Radiation Therapy Complication | Phase 2 | Status: SUSPENDED